Evaluation of Enhanced External Counterpulsation Therapy for Nonarteritic Anterior Ischemic Optic Neuropathy

Overview

Journal BMC Ophthalmol

Publisher Biomed Central

Specialty Ophthalmology

Date 2020 Jun 20

PMID 32552704

Citations 1

Authors

Lixia Lin

Wenhui Zhu

Nan Ma

Xiaofeng Lin

Hui Yang

Affiliations

Soon will be listed here.

Abstract

Background: To explore the effects of enhanced external counterpulsation (EECP) and its underlying influencing factors in nonarteritic anterior ischemic optic neuropathy (NAION) patients.

Methods: Patients at Zhongshan Ophthalmic Center with recent-onset (< 8 weeks) NAION were retrospectively recruited. The patients had decided whether or not they would undergo EECP treatment, and the patients who declined were included in the control group. The effectiveness of EECP was evaluated by comparing the visual function and fellow eye involvement in patients with and without EECP treatment.

Results: In total, 61 patients (76 eyes) were included. Twenty-nine patients (37 eyes) underwent EECP treatment, while 32 patients (39 eyes) were included in the control group. Mean time from NAION onset to EECP initiation was 27.59 ± 16.70 days. In the EECP group, the mean EECP duration was 31.57 ± 18.45 days. EECP was well tolerated by all patients. However, there was no significant difference in visual function between the EECP and control groups. Furthermore, there was no evidence of the effectiveness of EECP in the subgroup analysis of patients with different systemic health conditions. Among the 42 patients with monocular NAION, the sequential attack rate was comparable between the EECP (27.78%) and control (25.00%) groups.

Conclusion: This study is the first nonrandomized controlled study to evaluate the effectiveness of EECP in NAION patients. Unfortunately, we failed to demonstrate the effectiveness of EECP in NAION at the 6-month follow-up. Any further application of EECP in NAION patients should be cautious.

Citing Articles

Efficacy of enhanced extracorporeal counterpulsation combined with atorvastatin in the treatment of cognitive impairment after stroke.

Duan Y, Tang H World J Psychiatry. 2024; 13(12):1027-1036.

PMID: 38186722 PMC: 10768497. DOI: 10.5498/wjp.v13.i12.1027.

References

Raza A, Steinberg K, Tartaglia J, Frishman W, Gupta T . Enhanced External Counterpulsation Therapy: Past, Present, and Future. Cardiol Rev. 2016; 25(2):59-67. DOI: 10.1097/CRD.0000000000000122. View

Arora R, Chou T, Jain D, Fleishman B, Crawford L, McKiernan T . The multicenter study of enhanced external counterpulsation (MUST-EECP): effect of EECP on exercise-induced myocardial ischemia and anginal episodes. J Am Coll Cardiol. 1999; 33(7):1833-40. DOI: 10.1016/s0735-1097(99)00140-0. View

Kerr N, Chew S, Danesh-Meyer H . Non-arteritic anterior ischaemic optic neuropathy: a review and update. J Clin Neurosci. 2009; 16(8):994-1000. DOI: 10.1016/j.jocn.2009.04.002. View

Prescott C, Sklar C, Lesser R, Adelman R . Is intravitreal bevacizumab an effective treatment option for nonarteritic anterior ischemic optic neuropathy?. J Neuroophthalmol. 2012; 32(1):51-3. DOI: 10.1097/WNO.0b013e318240596e. View

Zhu W, Liao R, Chen Y, Liu L, Zhang Y . Effect of enhanced extracorporeal counterpulsation in patients with non-arteritic anterior ischaemic optic neuropathy. Graefes Arch Clin Exp Ophthalmol. 2014; 253(1):127-33. DOI: 10.1007/s00417-014-2823-z. View

Foroozan R . New Treatments for Nonarteritic Anterior Ischemic Optic Neuropathy. Neurol Clin. 2016; 35(1):1-15. DOI: 10.1016/j.ncl.2016.08.003. View

Sharma U, Ramsey H, Tak T . The role of enhanced external counter pulsation therapy in clinical practice. Clin Med Res. 2014; 11(4):226-32. PMC: 3917995. DOI: 10.3121/cmr.2013.1169. View

Luneau K, Newman N, Biousse V . Ischemic optic neuropathies. Neurologist. 2008; 14(6):341-54. DOI: 10.1097/NRL.0b013e318177394b. View

Hayreh S, Zimmerman M . Optic disc edema in non-arteritic anterior ischemic optic neuropathy. Graefes Arch Clin Exp Ophthalmol. 2007; 245(8):1107-21. DOI: 10.1007/s00417-006-0494-0. View

10.

Peeler C, Cestari D . Non-Arteritic Anterior Ischemic Optic Neuropathy (NAION): A Review and Update on Animal Models. Semin Ophthalmol. 2016; 31(1-2):99-106. DOI: 10.3109/08820538.2015.1115248. View

11.

Werner D, Michalk F, Harazny J, Hugo C, Daniel W, Michelson G . Accelerated reperfusion of poorly perfused retinal areas in central retinal artery occlusion and branch retinal artery occlusion after a short treatment with enhanced external counterpulsation. Retina. 2004; 24(4):541-7. DOI: 10.1097/00006982-200408000-00006. View

12.

Kollarits C, McCarthy R, CORRIE W, Swann E . Norepinephrine therapy of ischemic optic neuropathy. J Clin Neuroophthalmol. 1981; 1(4):283-8. View

13.

Aftab A, Iqbal M, Rauf A, Ali A . Non arteritic anterior ischemic optic neuropathy; does Anticoagulation help?. J Ayub Med Coll Abbottabad. 2017; 28(4):776-780. View

14.

Amin F, Al Hajeri A, Civelek B, Fedorowicz Z, Manzer B . Enhanced external counterpulsation for chronic angina pectoris. Cochrane Database Syst Rev. 2010; (2):CD007219. PMC: 7180079. DOI: 10.1002/14651858.CD007219.pub2. View

15.

Keren S, Zanolli M, Dotan G . Visual outcome following bilateral non-arteritic anterior ischemic optic neuropathy: a systematic review and meta-analysis. BMC Ophthalmol. 2017; 17(1):155. PMC: 5571512. DOI: 10.1186/s12886-017-0543-y. View

16.

Atkins E, Bruce B, Newman N, Biousse V . Treatment of nonarteritic anterior ischemic optic neuropathy. Surv Ophthalmol. 2009; 55(1):47-63. PMC: 3721361. DOI: 10.1016/j.survophthal.2009.06.008. View

17.

Wilhelm B, Ludtke H, Wilhelm H . Efficacy and tolerability of 0.2% brimonidine tartrate for the treatment of acute non-arteritic anterior ischemic optic neuropathy (NAION): a 3-month, double-masked, randomised, placebo-controlled trial. Graefes Arch Clin Exp Ophthalmol. 2005; 244(5):551-8. DOI: 10.1007/s00417-005-0102-8. View

18.

Pakravan M, Sanjari N, Esfandiari H, Pakravan P, Yaseri M . The effect of high-dose steroids, and normobaric oxygen therapy, on recent onset non-arteritic anterior ischemic optic neuropathy: a randomized clinical trial. Graefes Arch Clin Exp Ophthalmol. 2016; 254(10):2043-2048. DOI: 10.1007/s00417-016-3451-6. View

19.

Newman N, Scherer R, Langenberg P, Kelman S, Feldon S, Kaufman D . The fellow eye in NAION: report from the ischemic optic neuropathy decompression trial follow-up study. Am J Ophthalmol. 2002; 134(3):317-28. DOI: 10.1016/s0002-9394(02)01639-2. View

20.

Chang M, Keltner J . Risk Factors for Fellow Eye Involvement in Nonarteritic Anterior Ischemic Optic Neuropathy. J Neuroophthalmol. 2018; 39(2):147-152. DOI: 10.1097/WNO.0000000000000715. View